Compound: Dexanabinol
SMILES: O1c2c(c(O)cc(c2)C(CCCCCC)(C)C)[C@H]3CC(CO)=CC[C@@H]3C1(C)C
InChIKey: SSQJFGMEZBFMNV-PMACEKPBSA-N
Synonyms: Dexanabinol, 112924-45-5, HU-211, HU 211, Sinnabidol, 11-OH-delta(8)-Thc-dmh, 11-Hydroxy-delta-8-dmh-thc, 1,1-Dimethylheptyl-11-hydroxytetrahydrocannabinol, 5'(1,1-Dimethylheptyl)-7-hydroxyhexahydrocannabinol, 7-Hydroxy-delta-6-tetrahydrocannabinoldimethylheptyl, R6VT8U5372, 11-Hydroxy-delta(8)-tetrahydrocannabinol-dimethylheptyl, 1,1-Dimethylheptyl-7-hydroxy-delta(6)-tetrahydrocannabinol, 11-Hydroxymethyl-delta(8)-tetrahydrocannabinol-dimethylheptyl, PRS-211007, PA-50211, PRS-211007-000, (+)-HU-210, DTXSID40150235, 6H-Dibenzo(b,d)pyran-9-methanol, 3-(1,1-dimethylheptyl)-6a,7,10,10a-tetrahydro-1-hydroxy-6,6-dimethyl-, (6aS-trans)-, RefChem:132380, DTXCID0072726, (6aS,10aS)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6H,6aH,7H,10H,10aH-benzo(c)isochromen-1-ol, 11-oh-thc, Sinnabidiol, (6aS,10aS)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol, CHEMBL334533, PRS 211007-000, UNII-R6VT8U5372, 6H-DIBENZO(B,D)PYRAN-9-METHANOL, 3-(1,1-DIMETHYLHEPTYL)-6A,7,10,10A-TETRAHYDRO-1-HYDROXY-6,6-DIMETHYL-, (6AS,10AS)-, 6H-Dibenzo[b,d]pyran-9-methanol, 3-(1,1-dimethylheptyl)-6a,7,10,10a-tetrahydro-1-hydroxy-6,6-dimethyl-, (6aS,10aS)-, DEXANABINOL [MI], SINNABIDOL [WHO-DD], (6aS,10aS)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydro-6H-benzo[c]chromen-1-ol, SCHEMBL1649687, SCHEMBL29358335, CHEBI:230837, GLXC-05794, MEA92445, BDBM50067498, PDSP2_000937, AKOS015967265, DB06444, DA-62805, HY-106387, CS-0025698, NS00069217, Q962504, (6aS,10aS)-3-(1,1-Dimethyl-heptyl)-9-hydroxymethyl-6,6-dimethyl-6a,7,10,10a-tetrahydro-6H-benzo[c]chromen-1-ol, (6AS,10AS)-9-(HYDROXYMETHYL)-6,6-DIMETHYL-3-(2-METHYLOCTAN-2-YL)- 6A,7,10,10A-TETRAHYDROBENZO(C)CHROMEN-1-OL, (6aS,10aS)-9-(Hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydro-6H-dibenzo[b,d]pyran-1-ol, (6aS,7S)-3-(1,1-Dimethyl-heptyl)-9-hydroxymethyl-6,6-dimethyl-6a,7,10,10a-tetrahydro-6H-benzo[c]chromen-1-ol
Theoretical properties:
molecular_formula: C25H38O3
molecular_weight: 386.6 g/mol
exact_mass: 386.28209507 g/mol
formal_charge: 0
hydrogen_bond_donor_count: 2
hydrogen_bond_acceptor_count: 3
rotatable_bond_count: 7
heavy_atom_count: 28
topological_polar_surface_area: 49.7 Å²
isotope_atom_count: 0
covalently_bonded_unit_count: 1
Physical properties:
Descriptions:
pubchem: Dexanabinol is a 1-benzopyran.
chembl: DEXANABINOL is a small molecule listed in the ChEMBL database and has reached clinical trial phase 3.0.
wikipedia: Dexanabinol (HU-211 or ETS2101) is a synthetic cannabinoid derivative in development by e-Therapeutics plc. It is the "unnatural" enantiomer of the potent cannabinoid agonist HU-210. Unlike other cannabinoid derivatives, HU-211 does not act as a cannabinoid receptor agonist, but instead as an NMDA antagonist. It therefore does not produce cannabis-like effects, but is anticonvulsant and neuroprotective, and is widely used in scientific research as well as currently being studied for applications such as treating head injury, stroke, or cancer. It was shown to be safe in clinical trials and is currently undergoing Phase I trials for the treatment of brain cancer and advanced solid tumors.